The Chang Robotics Fund Invests In Curabotics

Curabotics is the future of healthcare automation, and the Chang Robotics Fund just bought a ticket to the front row.

Following their initial close on capital, the Chang Robotics Fund has selected Curabotics as one of the Fund's first official investments. Curabotics is a robotics and automation company dedicated to designing solutions that enhance hospital efficiency and alleviate the burden on medical professionals. Their most recent deployment of Nurse-Assist bots in a leading national hospital alleviated 15% of the average nurse’s daily workload spent on non-clinical tasks and has the potential, with full implementation, to alleviate 40%.

The healthcare industry is facing a critical challenge: escalating turnover of nurses and caregivers. For a large-sized hospital, turnover across all professional categories amounts to $21M - $43M in additional costs. This financial burden, coupled with the ongoing pressures of the post-pandemic healthcare environment, underscores the urgent need for innovative solutions that are widely adopted by healthcare professionals and improve the bottom line of hospitals and other healthcare facilities.  

Curabotics solves this problem by offering a platform of solutions that automate supply transportation, resulting in increased labor productivity, reduced caregiver burnout, improved patient satisfaction, and direct cost savings for hospital systems. Curabotics successfully deployed the first hospital-wide fleet of autonomous mobile collaborative robots to support nurses in a top-tier hospital system, resulting in a 96% nurse approval rating. This deployment is expected to save nurses up to 40% of their time, allowing them to focus on patient care and improve patient outcomes. 

Riyad Twahir - Managing Director

The market potential for Curabotics’ products is enormous, and the founding team, Kate McAfoose and Riyad Twahir, have proven they can sell into the most respected hospital brands in the US and successfully scale the business while keeping nurses, their key stakeholders’, interests at the center of the value proposition. The Chang Robotics Fund is thrilled to support Curabotics and its team’s mission and growth, and we look forward to seeing Curabotics’ products deployed in every major hospital system.

Curabotics plans to use the capital for scaling its operations and expanding its reach, as well as for the continuous development of its products.

Kate McAfoose - Co-Founder

“We’re thrilled to partner with the Chang Robotics Fund as we scale our Nurse-Assist technology to more hospitals. This investment is more than capital. It’s a strong vote of confidence in our mission to empower care teams, allowing clinicians to focus on patient care, thereby improving patient outcomes. We’re just getting started,” says Kate McAfoose, Co-Founder of Curabotics.

It's not too late to join the Fund and support the innovative companies we've handpicked to invest in. However, time is limited! Contact our team today by filling out the contact form on our website. Don't miss your chance to be part of this world-changing fund.

To learn more about Curabotics, visit www.curabotics.com and follow Curabotics on LinkedIn.